Issels Integrative Immuno-Oncology August 23, 2018  

After Surgery Treatment with Anti-Inflammatory Meds May Improve Breast Cancer Prognosis

Dear Friend,

Traditional cancer treatments such as chemotherapy and radiation are directed at fighting tumors head-on. Immunotherapy for cancer, which is aimed at making the body's immune system more effective against tumors, has created a fundamental change in the way doctors approach treatment.

A Long-Held "Medical Dream" Becomes Reality

While the earliest attempts at immunotherapy date back more than 100 years, it presented too much of a puzzle to doctors. As a result, radiation and chemotherapy surpassed immunotherapy as the treatments of choice for cancer.

As modern research with immunotherapy uncovered more effective methods with documented track records, medical and financial floodgates have opened. Charitable organizations, pharmaceutical companies and the federal government are dedicating billions of dollars to fund hundreds of trials involving various treatments on every type of cancer.

Boosting the Body's Own Immune System

While there is still much to learn, researchers are focusing primarily on two types of immunotherapy for cancer:

• In the first method, a doctor removes some of the patient's own immune cells and creates genetic alterations enabling them to attack cancer cells, at which point they are added back to the bloodstream.

• The second method makes use of drugs known as checkpoint inhibitors, which block the mechanism used by cancer cells to evade detection and attack by the immune system.

Cancer Immunotherapy for Late-Stage and Therapy-Resistant Tumors

Issels® non-toxic immunotherapy has a successful track record of helping patients with late-stage and therapy-resistant cancers achieve long-term remission. Visit our website to read and hear these stories from patients in their own words.

Email   Facebook   Twitter   Google+

After Surgery Treatment with Anti-Inflammatory Meds May Improve Breast Cancer Prognosis

Read more interesting articles on the "Issels Cancer Immunotherapy" news/blog posted every Tuesday and Thursday. Check It Out Now »


In The News: Low Dose Aspirin Reduces Cancer Death Risk

In early April, attendees at the American Association for Cancer Research meeting in Washington, D.C. learned why aspirin also holds promise for treating cancer patients.

Yin Cao, an instructor at Massachusetts General Hospital and Harvard Medical School, reviewed data from long-term health studies involving both men and women. While the overall risk of death was lower for individuals who took a daily dose of aspirin, Cao found that the risk of dying from cancer was 7 percent lower in women and 15 percent lower in men.

Get the Full Story!

How the Presence of Estrogen Protects Women from Gastric Inflammation Leading To Cancer

H. pylori infections are controlled by the body's immune system, but a common side effect is gastritis, which is an inflammation of the stomach. The result is conditions that lead to the development of gastric cancer.

Studies have indicated that estrogen can protect women from gastritis, lowering their gastric cancer risk. Conversely, Tamoxifen and other drugs that block estrogen have been linked to higher risk of gastric cancer in women.

Get the Full Story!

Videos – What Do Patients Say About Their Experience?

Watch videos of patients who share their own experiences at the Issels clinics with you. Listen to their stories and cancer journeys.

Get the Full Story!
Interested?

Learn More

Testimonials »

Treatments »

Vaccines »

Statistics »

History »

Locations »

Contact Us »

Connect With Us:


Google +

Contact Info:

Phone: 888-447-7357

Email: info@issels.com



Treatments | Testimonials | Contact Us